This company has been marked as potentially delisted and may not be actively trading.

NYSE:NVTA

Invitae (NVTA) Stock Price, News & Analysis

Invitae logo

About Invitae Stock (NYSE:NVTA)

Key Stats

Today's Range
$0.0003
▼
$0.0003
50-Day Range
N/A
52-Week Range
$0.02
▼
$0.02
Volume
N/A
Average Volume
23.72 million shs
Market Capitalization
$80.10 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

Receive NVTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invitae and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NVTA Stock News Headlines

Financial legend: “This is bad, really bad...”
Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leading Weiss Ratings, the only conflict-free rating agency in the US. Now he says a $3 trillion problem could trigger a chain reaction of crashes and failures, causing a global freeze in financial markets.tc pixel
See More Headlines

NVTA Stock Analysis - Frequently Asked Questions

Invitae Co. (NYSE:NVTA) released its earnings results on Tuesday, May, 9th. The medical research company reported ($0.37) earnings per share for the quarter, beating the consensus estimate of ($0.41) by $0.04. Invitae's quarterly revenue was down 5.1% compared to the same quarter last year.

Invitae (NVTA) raised $89 million in an initial public offering on Thursday, February 12th 2015. The company issued 6,350,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan acted as the underwriter for the IPO and Cowen and Company and Leerink Partners were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Invitae investors own include NVIDIA (NVDA), CRISPR Therapeutics (CRSP), Block (XYZ), Tesla (TSLA), PayPal (PYPL), Advanced Micro Devices (AMD) and Pinterest (PINS).

Company Calendar

Today
11/16/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
NYSE:NVTA
CIK
1501134
Fax
N/A
Employees
1,700
Year Founded
2010

Profitability

EPS (Trailing Twelve Months)
($5.38)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$3.11 billion
Net Margins
-299.14%
Pretax Margin
-301.93%
Return on Equity
-6,100.71%
Return on Assets
-19.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.39
Quick Ratio
2.25

Sales & Book Value

Annual Sales
$481.58 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.42 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
267,010,000
Free Float
284,373,000
Market Cap
$80.10 thousand
Optionable
Optionable
Beta
1.59

Social Links

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

This page (NYSE:NVTA) was last updated on 4/8/2026 by MarketBeat.com Staff.
From Our Partners